Kidney damage in polycythemia Vera as a problem of interdisciplinary interaction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Polycythemia vera is a rare chronic progressive clonal myeloproliferative disorder. In polycythemia vera, the pathological process involves the bone marrow, spleen and liver; kidneys are extremely rare involved. In the case of kidney damage, various pathogenetic mechanisms are implemented, ranging from fairly obvious ones, due to the hyperuricemia characteristic of this disease, and ending with complex mechanisms with the development of glomerular damage. The article presents a clinical observation of a patient with polycythemia vera and kidney damage, the interpretation of which required the joint efforts of specialists in various fields.

Full Text

Restricted Access

About the authors

Elena V. Voloshinova

Saratov State Medical University n.a. V.I. Razumovsky

Email: voloshinovaelena@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia

Karina N. Safarova

Saratov State Medical University n.a. V.I. Razumovsky

Email: k.tsaturova@yandex.ru
Teaching Assistant at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia

Elena V. Yakovleva

Saratov State Medical University n.a. V.I. Razumovsky

Email: elenaviktorova@yandex.ru
Cand. Sci. (Med.), Associate Professor at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia

Svetlana I. Sazhnova

Saratov State Medical University n.a. V.I. Razumovsky

Email: sazhnova.svetlana@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Hospital Therapy, Faculty of General Medicine Saratov, Russia

References

  1. Гематология. Национальное руководство. Под ред. О.А. Рукавицына. М., 2017. С. 696- 718.
  2. McMullin M.F. Idiopathic erythrocytosis: a disappearing entity. Hematol. Am. Soc. Hematol. Educ. Program. 2009. Р. 629-635.
  3. Marchioli R., Finazzi G, Landolfi R., et al. Cardiovascular events and intensity of treatment in polycythemia vera. N. Engl. J. Med. 2013;368(1):22-33.
  4. Chen H., Zhang B., Li M., et al. Polycythemia vera associated with IgA nephropathy: A case report and literature review. Exp. Ther. Med. 2015;10:555-560. doi: 10.3892/etm.2015.2572.
  5. Aristizabal-Alzate A., Munoz-Grajales C., Ocampo-Kohn C., et al. Nefritis tubulointersticial y colangitis esclerosante asociadas a pancreatitis autoimmune. Nefrol. 2012;32:854-856. doi: 10.3265/Nefrologia.pre2012.Aug.11185.
  6. Ulusoy S., Ozkan G., Sönmez M., et al. Absence of hypoalbuminemia despite nephrotic proteinuria in focal segmental glomerulosclerosis secondary to polycythemia vera. Int. Med. 2010;49:2477-2480. Doi: 10.2169/ internalmedicine.49.4087.
  7. Kosch M., August C, Hausberg M., et al. Focal sclerosis with tip lesions secondary to polycythaemia vera. Nephrol. Dial. Transplant. 2000;15:1710-1711. doi: 10.1093/ndt/15.10.1710-a.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies